Why Farbe Firma is the Top Manufacturer of Folic Acid (Vitamin B9) Injection
- Maulik Sudani
- 16 minutes ago
- 10 min read
Last Updated: July 4, 2026
TL;DR: Folic Acid (Vitamin B9) Injection - a sterile aqueous solution of folic acid (as sodium folate), the water-soluble vitamin B9 the body reduces to tetrahydrofolate, the coenzyme that carries the one-carbon units required for purine, thymidylate and DNA synthesis and for the remethylation of homocysteine to methionine, supplied commonly as a 5 mg/mL solution in an amber glass ampoule for intramuscular, slow intravenous or deep subcutaneous use - is the vitamin clinicians use to treat megaloblastic anaemia of folate deficiency and to correct folate deficiency in malabsorption, malnutrition, pregnancy and chronic haemolysis when the oral route is unsuitable. Because a light- and oxygen-sensitive vitamin that dissolves only at alkaline pH is injected into muscle or vein, each ampoule must deliver a sterile, correctly concentrated, characteristically yellow-orange solution held at the right pH, with the HPLC assay and related substances, solution pH, colour and clarity, particulate and endotoxin, a validated sterilisation route and verified container-closure integrity all mattering to potency and safety. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Folic Acid (Vitamin B9) Injection at our Gujarat, India facility and supplies it to haematology, obstetric, nephrology and hospital-pharmacy services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Water-soluble vitamin (vitamin B9 / folate) - folic acid is reduced by dihydrofolate reductase to tetrahydrofolate and its derivatives, the coenzymes that transfer one-carbon units in purine and thymidylate synthesis, in DNA and RNA formation and in the remethylation of homocysteine to methionine, and Folic Acid (Vitamin B9) Injection (a 5 mg/mL aqueous solution of sodium folate given intramuscularly, by slow intravenous injection or deep subcutaneously) demands a correctly concentrated, pH-controlled, particulate-free solution in every ampoule.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated compounding and ampoule filling under light protection and nitrogen, control of the folic acid assay and related substances by HPLC, solution pH held in the alkaline solubility window, colour and clarity, particulate and endotoxin, validated sterilisation, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, forced-degradation data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile water-soluble-vitamin ampoule contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Folic Acid (Vitamin B9) Injection Demands a Premium Manufacturer
Folic Acid (Vitamin B9) Injection holds an established place in haematology, obstetrics and nutrition across many markets. It is the therapy a clinician turns to when a patient's folate stores are depleted and the oral route is unreliable or too slow: in megaloblastic anaemia caused by folate deficiency, in the deficiency of intestinal malabsorption, coeliac disease and short-bowel states, in malnutrition and alcohol dependence, in the raised demand of pregnancy, lactation and chronic haemolytic anaemias such as sickle-cell disease and thalassaemia, and in patients on renal dialysis who lose folate into the dialysate. Folic acid is the stable synthetic form of vitamin B9; once in the body it is reduced by dihydrofolate reductase to dihydrofolate and then tetrahydrofolate, and it is tetrahydrofolate and its one-carbon derivatives that donate the carbon units needed to build the purine and thymidylate bases of DNA, to sustain the rapid cell division of the bone marrow, and - together with vitamin B12 - to remethylate homocysteine to methionine. What makes the parenteral form distinctive is certainty of delivery: in a patient who cannot absorb or retain oral folate, an accurately concentrated injection puts the vitamin where the marrow can use it, so the prescriber depends on an ampoule whose strength and sterility are beyond doubt.
That clinical reality places real demands on the manufacturer. Folic Acid (Vitamin B9) Injection is presented as a sterile aqueous solution - for example 5 mg/mL of folic acid in a 1 mL ampoule or a larger vial, given intramuscularly, by slow intravenous injection or by deep subcutaneous injection - so the concentration must be exact and the fill accurate. The first challenge is solubility: folic acid is practically insoluble in water at neutral or acidic pH and is brought into solution only as its sodium salt at an alkaline pH, so the solution is prepared with sodium hydroxide and the pH is held within a defined alkaline window, because any drift toward lower pH can let the vitamin precipitate out of solution. The second is instability to light and oxygen: folic acid is photosensitive and is degraded by light and air to pterin-6-carboxylic acid and p-aminobenzoyl-L-glutamic acid, so the solution is compounded, filled and packaged under light protection and a nitrogen blanket, the ampoule is amber, and photostability is characterised so the solution keeps its strength through storage. The assay must confirm the folic acid content and the related-substance methods must detect these degradation products, all by validated HPLC; the solution has a characteristic yellow to orange colour that must fall within a defined range - unlike a water-clear injection, here colour is itself a specified attribute and an unexpected change signals degradation; and the solution must be clear and free of visible and sub-visible particulate. Sterility is achieved by a validated route - terminal moist-heat sterilisation where the formulation and container allow, or sterilising-grade filtration followed by aseptic filling - with endotoxin held very low and container-closure integrity assured for the glass ampoule. Choosing a Folic Acid (Vitamin B9) Injection manufacturer that treats pH and solubility control, light and oxygen protection and colour and assay control as core disciplines is what protects the patient at the point of care.
What Sets a World-Class Folic Acid (Vitamin B9) Injection Manufacturer Apart
A world-class manufacturer of Folic Acid (Vitamin B9) Injection invests in three areas that weaker suppliers underfund: precise, validated control of the folic acid assay and related substances by HPLC - confirming the labelled content and detecting the pterin-6-carboxylic acid, aminobenzoylglutamate and other related substances a light- and oxygen-sensitive vitamin can form; disciplined pH, solubility and colour control across compounding, filling, sterilisation and packaging, because a vitamin that dissolves only at alkaline pH and carries a characteristic yellow-orange colour must be held in its stable window and must not darken or precipitate; and tender-ready dossier support, including the photostability, forced-degradation and sterilisation data, for a vitamin procured through haematology, antenatal and ministry-of-health channels. It starts with the raw materials - pharmacopoeial folic acid of controlled purity and water content, water for injection, sodium hydroxide for salt formation and pH adjustment, and where used an antioxidant and nitrogen - each sourced from qualified, audited suppliers with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production. Because the value of the product is a precise, stable dose of an undegraded vitamin held correctly in solution, the assay, the related substances and the photostability data are treated as central evidence rather than supporting annexes.
Compounding and filling then have to build - and defend - a correctly concentrated, pH-stable, characteristically coloured solution. The folic acid is dissolved in water for injection as its sodium salt under controlled alkaline pH, any antioxidant incorporated, the solution polished by filtration to remove particulate, and the whole operation carried out under light protection and a nitrogen blanket to prevent photo- and oxidative degradation. The solution is passed through a sterilising-grade filter and filled into amber glass ampoules under ISO Class 5 conditions with a nitrogen headspace, the ampoules sealed and then sterilised by a validated route - terminal moist-heat where the formulation and container permit, giving a robust sterility assurance level, or aseptic filling where terminal heat is not appropriate. Filled units are 100 % inspected for fill, seal, clarity, colour and particulate; in-process and release testing confirm the folic acid assay and concentration, the related-substance profile by HPLC, solution pH against its alkaline limits, colour and clarity within defined limits, visible and sub-visible particulate matter, deliverable volume, and that endotoxin is held well within limits so the solution is safe for intramuscular, intravenous or subcutaneous use. Because the product is a light- and oxygen-sensitive vitamin held in solution only at the right pH, the assay, the related substances, the pH and the colour are confirmed together, before and after the sterilisation cycle, so the solution that leaves the plant is the same correctly concentrated, in-specification solution the specification requires - with no precipitation, no darkening and no out-of-limit degradation in the ampoule across shelf life.
Quality Systems Behind Every Folic Acid (Vitamin B9) Injection
Every Farbe Firma Folic Acid (Vitamin B9) Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of folic acid against reference standards, control of related substances and photodegradation products, solution pH against its defined alkaline window, colour and clarity of solution against defined limits, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the amber glass ampoule. Certificates of analysis are issued with full traceability back to each folic acid lot, the primary-packaging lot and the qualified person responsible for release. Because the product is light- and oxygen-sensitive and is held in solution only at alkaline pH, the assay, the related substances, the pH and the colour are qualified across the process so the vitamin's stability is demonstrated rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated sterilisation and ampoule-filling equipment with nitrogen blanketing and 100 % inspection, sterilising-grade filtration with filter-integrity testing, light-protected compounding, holding and packaging, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because a water-soluble vitamin whose job is to restore the bone marrow's ability to make DNA is given directly into muscle or the bloodstream and its potency depends on an undegraded, correctly concentrated molecule in a stable solution, we treat the assay, the related substances, the pH, the colour and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated conditions and ICH Q1B photostability, with the assay, related substances and colour followed across the study, so the solution stays in specification across the labelled shelf life, and the protect-from-light storage instructions on the label are supported by real data.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Folic Acid (Vitamin B9) Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad vitamin, haematology and general-injectables portfolio. For Folic Acid (Vitamin B9) Injection specifically, we supply the water-soluble vitamin B9 as a 5 mg/mL aqueous solution of sodium folate in amber glass ampoules, together with other strengths and fill volumes, under WHO-GMP conditions, with country-specific strengths, fill volumes, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the assay, related-substance, photostability, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Folic Acid (Vitamin B9) Injection can request the assay, related-substance and accelerated- and photo-stability summaries up front, which is often the deciding technical evidence for a vitamin injectable in hospital-formulary and ministry-of-health review, since it is the confirmed potency of an undegraded vitamin and a validated sterility assurance that separate a dependable folic acid injection from an unreliable one.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, forced-degradation packages, sterilisation and container-closure reports, translated package inserts and artwork - including the intramuscular, slow-intravenous and deep-subcutaneous administration instructions, the caution that folic acid alone should not be used to treat an undiagnosed megaloblastic anaemia until vitamin B12 deficiency has been excluded, and the protect-from-light storage directions - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Folic Acid (Vitamin B9) Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the light-protected, nitrogen-blanketed compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through folic acid sourcing and purity control, the formation of the sodium salt and control of the alkaline solubility window, the design of a pH-stable, light- and oxygen-protected water-soluble vitamin solution, the assay and related-substance strategy by HPLC, the choice and validation of terminal moist-heat or aseptic sterilisation, colour, clarity and particulate control, photostability, fill and concentration accuracy, endotoxin control, container-closure integrity and shelf-life choices in real detail. For a water-soluble vitamin where assay accuracy, pH and colour stability and sterility directly govern potency and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Folic Acid (Vitamin B9) Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Folic Acid (Vitamin B9) Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, dedicated light-protected and nitrogen-blanketed compounding and ampoule filling, sterilising-grade filtration, validated terminal moist-heat or aseptic sterilisation, 100 % inspection and continuous environmental monitoring.
Which strengths and presentations of Folic Acid (Vitamin B9) Injection do you supply?
Our water-soluble vitamin B9 solution is available as a 5 mg/mL aqueous solution of folic acid (as sodium folate) in amber glass ampoules, for intramuscular, slow intravenous or deep subcutaneous use. Custom strengths, fill volumes, container formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Folic Acid (Vitamin B9) Injection mainly used for?
Folic Acid (Vitamin B9) Injection is used to treat megaloblastic anaemia due to folate deficiency and to correct folate deficiency in malabsorption, malnutrition, pregnancy and lactation, chronic haemolytic anaemia and renal dialysis when the oral route is unsuitable. It is given intramuscularly, by slow intravenous injection or by deep subcutaneous injection. Folic acid alone should not be used for an undiagnosed megaloblastic anaemia until vitamin B12 deficiency is excluded, because it can correct the blood picture while allowing neurological damage to progress. Farbe Firma verifies the assay, related substances, pH, colour and clarity, particulate matter and endotoxin at release so each ampoule delivers a correctly concentrated solution.
Can Farbe Firma support country-specific registrations for Folic Acid (Vitamin B9) Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, related-substance and forced-degradation packages, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Folic Acid (Vitamin B9) Injection contract manufacturing?
MOQs vary by strength, fill volume, label complexity and dossier requirements. For our aqueous ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments